pLenti-SF3B1-K700E-reporter
(Plasmid
#200318)
-
PurposeA fluorescent reporter for SF3B1 K700E mutation. Co-expresses a blasticidin resistance gene for selection. Includes LoxP sites for Cre-mediated deletion of reporter cassette.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 200318 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti
- Total vector size (bp) 7538
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameBSD-2A-EGFPi
-
Alt nameLoxP-WPRE-EF1a-BSD-P2A-EGFP(exon 1)-synMTERFD3i1-150-EGFP(exon 2)-LoxP
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2298
- Promoter EF1-a
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer Whole plasmid sequencing with Primordium.
- 3′ sequencing primer Whole plasmid sequencing with Primordium. (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2024.02.23.581842 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti-SF3B1-K700E-reporter was a gift from Lili Wang (Addgene plasmid # 200318 ; http://n2t.net/addgene:200318 ; RRID:Addgene_200318) -
For your References section:
Engineering oncogenic hotspot mutations on SF3B1 via CRISPR-directed PRECIS mutagenesis. Fernandez M, Yu L, Jia Q, Wang X, Hart KL, Jia Z, Lin RJ, Wang L. Cancer Res Commun. 2024 Aug 28. doi: 10.1158/2767-9764.CRC-24-0145. 10.1158/2767-9764.CRC-24-0145 PubMed 39194178